Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
Omega DUROS® is an implantable drug delivery system designed to deliver omega interferon subcutaneously at a constant rate for 90 days. This study is being performed to evaluate the safety and antiviral effects of omega interferon delivered by the Omega DUROS® device in combination with ribavirin in subjects with chronic Hepatitis C genotype 1.
Epistemonikos ID: 6cf9a20956ca40092601d53e91caf50b77684850
First added on: May 04, 2024